6-10| NOV. | 2022
Nov
10
Nov
9
Nov
9
Nov
9
Maria Jasin (Memorial Sloan-Kettering Cancer Center, New York)
Homologous recombination as a safeguard against tumorigenesis
Nov
9
Nov
9
Nov
9
Nov
9
Nov
9
Diana L. Bordin (Akershus University Hospital, Oslo, Norway)
A national precision cancer medicine implementation initiative for Norway
Nov
9
Jean-Yves Masson (Laval University, Quebec, Canada)
PALB2: from molecular functions to the effect of PARP inhibitors on specific missense mutations
Nov
9
Reuben Harris (University of Minnesota)
DNA deaminase-catalyzed mutation in human disease
Nov
9
Nov
9
Nov
9
Nov
9
Nov
9
Nov
9
Keith Caldecott (University of Sussex, UK)
Sources of endogenous DNA single-stand breakage and associated pathology, in human genetic disease
Nov
9
Nima Mosammaparast (Washington University, St. Louis)
How RNA processing links to DNA repair
Nov
9
Nina Papavasiliou (DKFC, Heidelberg, Germany)
Consequences of collateral DNA damage due to "off target" RNA editing
Nov
9
Nov
9
Nov
9
Johannes Walter (Harvard Med. School, Boston)
Transcription-coupled DNA repair in a test tube
Nov
9
Barbara van Loon (NTNU, Trondheim, Norway)
Crosstalk between base excision repair and gene expression
Nov
9
Nov
9
Nov
9
Nov
8
Nov
8
Nov
8
Nov
8